Key result
Agent-based mathematical model successfully simulates BP lowering effects of antihypertensive monotherapies and combinations.
Why the study?
Hypertension is a multifactorial disease with variable individual treatment responses, making in silico evaluation of antihypertensive therapy efficacy an important clinical task.
Can a modular agent-based model simulate the response to various antihypertensive therapies in virtual patients?
Can a modular agent-based model simulate the response to various antihypertensive therapies in virtual patients?
An extended mathematical model successfully simulates the pharmacodynamic effects of various antihypertensive drugs, paving the way for personalized medicine predictions.
No takes yet. Share an insight, caveat, or question.
May enable in silico exploration of antihypertensive combinations; leaves open prospective validation before guiding personalized therapy.
Kutumova et al. (2022) studied Hypertension (n=1,000). Antihypertensive therapy (aliskiren, amlodipine, bisoprolol, enalapril, hydrochlorothiazide, losartan) vs. Baseline (untreated virtual patients) was evaluated on Simulated blood pressure response to antihypertensive therapies. A modular agent-based mathematical model successfully simulated the expected blood pressure lowering effects of various antihypertensive monotherapies and their combinations in a population of 1,000 virtual patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: